Knowledge and News for the Global Fight Against Cancer.
Pain drugmaker Latigo Biotherapeutics successfully completed its initial public offering (IPO) on Thursday, August 7,...
Dr. Erica Schwartz has been confirmed as the next director of the Centers for Disease...
Tarsus Pharmaceuticals, a prominent developer of treatments across ophthalmology, dermatology, and infectious diseases, has announced...
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Replimune’s novel...
The U.S. Food and Drug Administration (FDA) has granted approval to Orzeyful, a novel medicine...
The U.S. Food and Drug Administration (FDA) has granted approval for mFlusiva, previously known as...
Braveheart Bio, a rapidly emerging biotechnology company focused on cardiovascular therapies, has successfully completed its...
The intense rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly in the burgeoning market...
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
Expedition Therapeutics, a rapidly emerging biotechnology company focused on bringing innovative therapies to market, announced...
admin